Christopher Canfield, DO
Nephrology in Philadelphia, PA
About Dr. Christopher Canfield
Dr. Christopher Canfield is a physician specializing in nephrology practicing in Philadelphia, PA, a graduate of Philadelphia College of Osteopathic Medicine (2018). Records list 2 practice addresses. Affiliated with Jefferson Health-Northeast, Temple University Hospital, Bma of Cambria and 1 more. Treated 237 Medicare patients in 2024.
| Specialty | NephrologyOther nephrology doctors in Philadelphia |
|---|---|
| Credentials | DO |
| Education | Philadelphia College of Osteopathic Medicine, 2018CMS Doctors and Clinicians |
| Gender | Male |
| NPI number | 1457855652National Provider Identifier (CMS NPPES), issued March 2018 |
| Medicare | Enrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians |
Where Dr. Christopher Canfield practices
- Metropolitan Nephrology Associates, P.c. 4453 Castor Ave, Suite B, Philadelphia, PA 19124 (215) 744-2266 · Directions · group of 9 clinicians
- Temple Physicians Inc 7500 Central Ave, Suite 107a, Philadelphia, PA 19111 (215) 379-6444 · Directions · group of 158 clinicians
Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.
Dr. Christopher Canfield's specialties and state licenses
| Specialty (NPPES) | License |
|---|---|
| Nephrology Primary | PA OS022674 |
As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.
Hospital affiliations of Dr. Christopher Canfield
- Jefferson Health-NortheastHospital · Philadelphia, PA
- Temple University HospitalHospital · Philadelphia, PA
- Bma of CambriaDialysis facility · Philadelphia, PA
- Fresenius Medical Care ParkviewDialysis facility · Philadelphia, PA
CMS Facility Affiliation data: facilities where the clinician bills Medicare.
Dr. Christopher Canfield's Medicare patients and services (2024)
Most frequent services
| Service | Times | Avg. Medicare allowed |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 247 | $79.46 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 141 | $355.58 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 59 | $131.89 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 37 | $119.33 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 28 | $131.53 |
| Transitional care management services for problem of high complexity | 23 | $285.67 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 21 | $184.46 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 19 | $16.65 |
Common conditions among these patients
Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.
Dr. Christopher Canfield's Medicare quality score (MIPS 2024)
The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.
Payments from drug and device companies to Dr. Christopher Canfield (2025)
$1,380.24 in 50 general payments reported in 2025.
| Type | Payments | Amount |
|---|---|---|
| Food and beverage | 50 | $1,380.24 |
Paying companies: Novo Nordisk Inc ($225.72), NOVARTIS PHARMACEUTICALS CORPORATION ($208.98), Ardelyx, Inc. ($185.15), AKEBIA THERAPEUTICS INC ($87.15), Bayer HealthCare Pharmaceuticals Inc. ($81.67), Amgen Inc. ($80.53).
Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.
Questions about Dr. Christopher Canfield
What kind of clinician is Dr. Christopher Canfield?
Dr. Christopher Canfield is listed as a physician specializing in nephrology.
Where does Dr. Christopher Canfield practice?
Metropolitan Nephrology Associates, P.c. at 4453 Castor Ave, Suite B, Philadelphia, PA 19124, and 1 other address in the records.
What is the office phone number for Dr. Christopher Canfield?
The listed office number is (215) 744-2266. Call to confirm availability and whether new patients are accepted.
What is the NPI number of Dr. Christopher Canfield?
The National Provider Identifier is 1457855652.
Does Dr. Christopher Canfield accept Medicare?
Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.
Which hospitals is Dr. Christopher Canfield affiliated with?
Jefferson Health-Northeast, Temple University Hospital, Bma of Cambria, Fresenius Medical Care Parkview.
Where did Dr. Christopher Canfield go to medical school?
Philadelphia College of Osteopathic Medicine, graduating in 2018.
Where this information comes from
| CMS Doctors and Clinicians | Name, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026) |
|---|---|
| NPPES NPI registry | NPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2023-11-14 |
| Facility affiliations | Hospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services |
| Medicare utilization | Patients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024 |
| MIPS | Quality payment program scores.CMS clinician public reporting, PY 2024 |
| Open Payments | Payments from drug and device companies.CMS Open Payments, program year 2025 |
Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.